Jaguar Health, Inc. Note Agreements
27 Contracts & Agreements
- Note Purchase Agreement, dated January 19, 2021, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC (Filed With SEC on January 22, 2021)
- Secured Promissory Note, dated January 19, 2021, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC (Filed With SEC on January 22, 2021)
- Promissory Note, dated October 1, 2019, between Napo Pharmaceuticals, Inc. and Michael Tempesta (Filed With SEC on October 7, 2019)
- Secured Promissory Note, dated May 28, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P (Filed With SEC on June 3, 2019)
- Secured Promissory Note, dated May 28, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P (Filed With SEC on June 3, 2019)
- Form of 125% Coverage Promissory Note (Filed With SEC on March 22, 2019)
- Form of 75% Coverage Promissory Note (Filed With SEC on March 22, 2019)
- Note Purchase Agreement, dated September 11, 2018, by and between Jaguar Health, Inc. and Charles Conte (Filed With SEC on September 12, 2018)
- Note Purchase Agreement, dated September 11, 2018, by and between Jaguar Health, Inc. and L2 Capital, LLC (Filed With SEC on September 12, 2018)
- Convertible Promissory Note, dated September 11, 2018, by and between Jaguar Health, Inc. and Charles Conte (Filed With SEC on September 12, 2018)
- Convertible Promissory Note, dated September 11, 2018, by and between Jaguar Health, Inc. and L2 Capital, LLC (Filed With SEC on September 12, 2018)
- Secured Promissory Note, dated March 21, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P (Filed With SEC on March 27, 2018)
- Secured Promissory Note, dated February 26, 2018, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P (Filed With SEC on March 2, 2018)
- Second Amendment to the Note Purchase Agreement and Notes and Payoff Agreement, dated February 16, 2018, by and among Jaguar Health, Inc. and the purchasers named therein (Filed With SEC on February 16, 2018)
- Form of Second Amended Original Issue Discount Exchangeable Promissory Note (Filed With SEC on February 16, 2018)
- First Amendment to the Note Purchase Agreement and Notes, dated December 29, 2017, by and among Jaguar Health, Inc. and the purchasers named therein (Filed With SEC on January 2, 2018)
- Form of First Amended Original Issue Discount Exchangeable Promissory Note (Filed With SEC on January 2, 2018)
- Secured Promissory Note, dated December 8, 2017, by and between Jaguar Health, Inc. and Chicago Venture Partners, L.P (Filed With SEC on December 14, 2017)
- SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on July 3, 2017)
- FORM OF CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 18, 2017)
- AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (Filed With SEC on April 18, 2017)
- FORM OF EXCHANGEABLE PROMISSORY NOTE (Filed With SEC on April 18, 2017)
- NOTE PURCHASE AGREEMENT (Filed With SEC on April 18, 2017)
- JAGUAR ANIMAL HEALTH, INC. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 17, 2015)
- FORM OF JAGUAR ANIMAL HEALTH, INC. NOTE EXERCISE AMENDMENT AND CONVERSION AGREEMENT (Filed With SEC on April 17, 2015)
- FORM OF JAGUAR ANIMAL HEALTH, INC. JUNE/2014 CONVERTIBLE NOTE EXERCISE AMENDMENT (Filed With SEC on April 17, 2015)
- JAGUAR ANIMAL HEALTH, INC. FORM OF CONVERTIBLE PROMISSORY NOTE (Filed With SEC on March 20, 2015)
